Daily as of 2 Nov 16:00 ET
- Price
- above both $14.13 vs 50 $12.58 / 200 $13.22
- Projection
- ๐จGolden cross estimated in 12 to 18 bars
- Test
- No active test
- Last cross
- ๐Death cross 26 Nov 2025 ยท projected 13 bars out ยท tested 6 bars
Dr. Reddy's Laboratories (RDY) is a NYSE-listed ADR that Cruxta has tracked for 50/200 crosses since 2018.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Nov 2025, but the two have been closing on each other and a golden cross is projected within 20 bars. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 27 Oct 2026 | ๐จGolden | 4-hour | 27 bars out | Not tested |
| week of 24 Aug 2026 | ๐Death flat | weekly | 10 bars out | Not tested |
| 27 Jul 2026 | ๐Death | 4-hour | 28 bars out | Not tested |
| 6 Jul 2026 | ๐จGolden | 4-hour | 22 bars out | 3 bar cross test |
| 7 Apr 2026 | ๐Death | 4-hour | 17 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.